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Abstract
There is indisputable evidence from epidemiologic and clinical studies that being overweight and
obese elevates the risk of developing debilitating and costly chronic diseases, including
hypertension, hypercholesterolemia, type 2 diabetes, cardiovascular diseases (CVD), and cancer
(1). Nonetheless, the relationship between body mass index (BMI) and mortality remains the
subject of much debate. A recent meta-analysis concluded that compared to those of normal
weight (BMI<25.0), overweight individuals (BMI 25.0–29.9) had a significantly lower mortality
risk (2). Even Class 1 obesity (BMI 30–34.9) was associated with marginally reduced mortality. In
this Perspective, we discuss why this finding is likely to be an artifact of methodological
limitations and what the clinical and public health implications may be.
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Methodological Biases in BMI and Mortality Analysis
Although total mortality is a straightforward endpoint, epidemiologic studies of body weight
and mortality are particularly prone to two major sources of bias: reverse causation and
confounding by smoking (3). Reverse causation is a concern when a lower body weight is
the result of an underlying illness through the disease process itself, or through a conscious
effort to lose weight motivated by a clinical diagnosis. Furthermore, this potential for bias
increases with older age as chronic diseases accumulate. While exclusion of participants
with known disease at baseline addresses much of this bias, many chronic conditions such as
pulmonary and neurodegenerative diseases remain undiagnosed for years. There is no
perfect solution to deal with this problem; however, excluding deaths occurring early in
follow-up can also help to reduce reverse causation.
Confounding by smoking is another major threat to BMI-mortality analysis. Differences in
intensity, inhalation, frequency, and duration, coupled with smoking’s very strong
association with mortality risk and association with lower body weight, make simply
adjusting for smoking status in a statistical model an inadequate control for its confounding.
To avoid this residual bias, it is now standard practice to conduct the analyses restricted to
never smokers.
These methodological biases are exacerbated when a wide comparison group (BMI 18.5 to
<25) is used because this group (especially the lower end of normal weight) contains not
Corresponding Author: Frank B. Hu, 665 Huntington Avenue Boston, MA 02115, frank.hu@channing.harvard.edu, Phone:
617.432.0113.
NIH Public Access
Author Manuscript
Obesity (Silver Spring). Author manuscript; available in PMC 2014 March 01.
Published in final edited form as:
Obesity (Silver Spring). 2013 September ; 21(9): . doi:10.1002/oby.20602.
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
tonly those who are lean and active, but also heavy smokers, individuals with chronic
diseases, and frail elderly individuals. In populations undergoing nutritional transitions (e.g.,
China and India), low BMI groups also include those affected by malnutrition and infectious
diseases. Comparing overweight and obese groups to this heterogeneous stratum seriously
underestimates their relative mortality risk.
As mentioned above, it is critical to conduct stratified analysis by smoking status. For
example, in the Prospective Studies Collaboration (Figure 1), there was an approximately
linear relationship among the never smokers, while a nonlinear J-shaped relationship
persisted among smokers (4). The lack of subgroup analyses among non-smokers or
individuals <65 years old casts doubt on the validity of conclusions derived from the meta-
analysis by Flegal et al.
What Have Other Studies Shown?
Flegal et al. emphasize that a strength of their meta-analysis is their use of standard BMI
categories. While the separate sensitivity analyses included EXTRAPOLATED
ESTIMATES FROM SEVERAL large studies, the main analysis excluded MANY LARGE
COHORTS OR CONSORTIA (Table 1) (4–9) which had sufficient statistical power to
allow for the analysis of finer BMI categories and assessment or non-linear associations.
Including only studies with broad BMI cut-points therefore resulted in an over-
representation of smaller clinical populations, high-risk patients with particular illnesses or
living in metabolic wards, and the elderly. In the excluded studies (>6 million individuals),
the lowest mortality was frequently observed among those with BMI 22.5–25, especially
among healthy nonsmokers (Table 1). These studies provide convincing evidence that
optimal BMI for longevity is below a BMI of 25.
Generalizability vs. Validity
It has been argued that exclusion of participants with CVD and cancer at baseline produce
misleading associations between BMI and mortality because the resulting sample would not
reflect the US population. However, these exclusions are necessary to obtain valid estimates
of mortality risk. For example, in a study of cigarette smoking and mortality, if patients with
CVD and cancer at baseline were included, the effects of smoking in the general population
would be seriously underestimated, as the “nonsmoking” patients would include ex-smokers
who quit due to illness but remain at an elevated risk of early death. Clearly, validity is the
overriding objective of epidemiologic studies, because non-valid results cannot be
generalized to any populations, including its own participants. From a public health
perspective, our ultimate goal is to identify the optimal BMI to reduce risk of chronic
disease and premature mortality, rather than pure statistical prediction.
Obesity Paradox
Obesity has been associated with improved survival in patients with existing chronic
diseases, including congestive heart failure (CHF), chronic obstructive pulmonary disease
(COPD), chronic kidney disease, and other wasting conditions —a phenomenon referred to
as “reverse epidemiology” or the “obesity paradox” (1). In these ill patients, other
cardiovascular risk factors (e.g., blood pressure and serum cholesterol) are also inversely
associated with mortality. One hypothesis proposed to explain these phenomena is that
obese patients benefit from a metabolic or nutritional reserve, improving their survival in
conditions of illness; however, a more plausible explanation for the “reverse epidemiology”
is the presence of methodological problems, especially reverse causation and survival bias.
Clinically, weight gain is not a desirable recommendation for most chronically ill patients,
who are often already overweight or obese to begin with.
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Flegal et al. suggest that their meta-analysis may “help to inform decision making in the
clinical setting.” However, their conclusion suggesting a reduced mortality among the
overweight and Class I obese patients is flawed and misleading. While not all overweight
and obese adults presently display signs of metabolic dysfunction or disease, this state
deemed “metabolically healthy obesity” has been shown to be only transitory for most (10).
Maintaining a healthy weight through diet and physical activity should remain the
cornerstone to prevention and treatment of chronic diseases, and is critical for reducing
skyrocketing health care costs. In addition to monitoring body weight, monitoring changes
in waist circumference and the amount of weight gain since young adulthood is also
important for enjoying a long and healthy life.
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All-cause mortality at ages 35–79 years versus BMI in the range 15–50 kg/m2, by smoking
status (excluding the first 5 years of follow-up), Reproduced with permission from
Prospective Studies Collaboration (4)
“Relative risks at ages 35–79 years, adjusted for age at risk, sex, and study, were multiplied
by a common factor (ie, floated) so that the mean for all participants (including ex-smokers
and anyone with missing smoking data) matches the European rate at ages 35–79 years in
2000. Results for ex-smokers and those with missing smoking data not shown (but are, taken
together, only slightly above those for never smokers). Note that many smokers were at only
limited risk, since they had not smoked many cigarettes during early adult life, or had
stopped shortly after the baseline survey. Risk is indicated on an additive rather than
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tmultiplicative scale. The estimates for 35–50 kg/m2 are based on limited data, so lines
connecting to those estimates are dashed. Floated mortality rates shown above each square
and numbers of deaths below. Area of square is inversely proportional to the variance of the
log risk. Boundaries of BMI groups are indicated by tick marks. 95% CIs for floated rates
reflect uncertainty in the log risk for each single rate.” (Whitlock G, Lewington S, Sherliker
P, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative
analyses of 57 prospective studies. Lancet 2009;373:1083–96. Figure 6.
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